Cargando…
Protease-activated receptor-1 (PAR1) promotes epithelial-endothelial transition through Twist1 in hepatocellular carcinoma
BACKGROUND: Tumor cells transfer into endothelial cells by epithelial–endothelial transition (EET), which is characterized by vasculagenic mimicry (VM) in morphology. VM can change tumor microcirculation, progression, and metastasis. However, the molecular mechanisms of endothelial-like transition r...
Autores principales: | Xiao, Ting, Zhang, Qiang, Zong, Shumin, Zhong, Wei-long, Qin, Yuan, Bi, Zhun, Chen, Shuang, Liu, Hui-juan, Wei, Jun-jie, Zhou, Bi-jiao, Wang, Lu-meng, Zhou, Hong-gang, Liu, Yan-rong, Sun, Tao, Yang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091192/ https://www.ncbi.nlm.nih.gov/pubmed/30081924 http://dx.doi.org/10.1186/s13046-018-0858-4 |
Ejemplares similares
-
linc-ROR facilitates hepatocellular carcinoma resistance to doxorubicin by regulating TWIST1-mediated epithelial-mesenchymal transition
por: Zhang, Yuanbiao, et al.
Publicado: (2021) -
KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal Transition
por: Hu, Bo, et al.
Publicado: (2019) -
Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1
por: Zhao, Xiu-lan, et al.
Publicado: (2011) -
Mutant CFTR Drives TWIST1 mediated epithelial–mesenchymal transition
por: Quaresma, Margarida C., et al.
Publicado: (2020) -
Histone 2B Facilitates Plasminogen-Enhanced Endothelial Migration through Protease-Activated Receptor 1 (PAR1) and Protease-Activated Receptor 2 (PAR2)
por: Das, Mitali, et al.
Publicado: (2022)